K202218 is an FDA 510(k) clearance for the ZelanteDVT THrombectomy System, ZelanteDVT ClotHunter Helical Rotation Device. This device is classified as a Peripheral Mechanical Thrombectomy With Aspiration (Class II - Special Controls, product code QEW).
Submitted by Boston Scientific Corporation (Maple Grove, US). The FDA issued a Cleared decision on October 2, 2020, 57 days after receiving the submission on August 6, 2020.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.5150. To Mechanically Disrupt Thrombus And/or Debris Prior To Removal From The Peripheral Vasculature Through Aspiration..